Reconfirmed at $627 ? $652 Million GAAP Basic and Diluted Net Income of $0.35 and $0.34 Per Share, Respectively, for 1Q10 NON-GAAP Basic and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cubist Pharmaceuticals 1Q10 Total Net Revenues Up ...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account